MedPath

effects of rice bran oil capsule on glycemic indices, antioxidant and inflammatory indicators patients with type 2 diabetes

Phase 2
Recruiting
Conditions
Type 2 diabetes mellitus.
Type 2 diabetes mellitus
Registration Number
IRCT20180205038626N12
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients with an age range of 20 to 70 years
Patients diagnosed with type 2 diabetes under drug therapy
Serum glucose greater than 110 mg/dL
Hemoglobin A1C maximum 9%
Body mass index in the range of 25-30
Not using vitamin and mineral supplements, antioxidants, fiber supplements, omega-3
No history of kidney disease, kidney stones, digestive diseases, gallstones, and autoimmune diseases
No current consumption of alcohol
Not taking insulin

Exclusion Criteria

Change in the patient's disease treatment plan during the study
Changing the type of drugs used, effective factors studied
Reluctance to continue the study or cause any dissatisfaction regarding the taste of the oil or participation in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath